Welcome to HCV Advocate’s hepatitis blog. The intent of this blog is to keep our website audience up-to-date on information about hepatitis and to answer some of our web site and training audience questions. People are encouraged to submit questions and post comments.
For more information on how to use this blog and search the HCV drug pipeline click here; for more information on HCV clinical trials click here
Tuesday, May 15, 2012
National Campaign Aims to End Hepatitis B in High-Risk Asian American and Pacific Islander Populations
Chronic hepatitis B is a liver disease caused by the hepatitis B virus (HBV) and is widely known as a “silent killer” because it can slowly destroy the liver without causing noticeable symptoms. More than half of the estimated 2 million people infected with HBV in the U.S. are AAPI. The primary goal of Hep B United is to support the success of community-based groups across the U.S. working to increase hepatitis B awareness, screening, vaccination, and access to care and treatment for all Americans, particularly AAPI populations disproportionately impacted by the disease.